Global Clinical Trial Supplies

Clinical Trial Supplies Comprehensive Study by Type (Manufacturing, Packaging and Labeling, Logistics and Distribution (Cold chain based, Non-cold chain based)), Application (CNS & Mental Disorders, Cardiovascular, Oncology), Phase (Phase I, Phase II, Phase III), End User (Contract Research Organizations, Pharmaceutical and Biotechnology Companies), Therapeutic Area (Oncology, Cardiovascular Diseases, Respiratory Diseases, CNS And Mental Disorders, Dermatology, Blood Disorders, Infectious Diseases, Others) Players and Region - Global Market Outlook to 2028

Clinical Trial Supplies Market by XX Submarkets | Forecast Years 2023-2028 | CAGR: 7.3%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
The Clinical trial is a research study that determines whether a medical strategy, treatment, or device is safe, effective and useful for humans use. These studies help to find which medical approaches experiment is best for certain diseases. A clinical trial provides the best data for health care decision-making purposes. Owing to the increasing cost of drug discovery, the market for clinical trial supplies is gaining traction. Also due to the implementation of strict handling guidelines towards a range of biopharmaceutical products that are entering the clinical trials, the strategy of clinical trial supply needs to be frequently overhauled which creates need towards integrating a large number of third-party vendors in all stages of clinical development.

AttributesDetails
Study Period2018-2028
Base Year2022
High Growth MarketAsia Pacific
UnitValue (USD Million)
Key Companies ProfiledKLIFO A/S (Denmark), Movianto (Germany), lamc Group LTD (United Kingdom), Catalent Pharma Solutions, Inc. (United States), PCI Services (United States), Patheon, Inc. (United States), Biocair (United Kingdom), Thermo Fisher Scientific, Inc. (United States), PAREXEL International Corporation (United States) and Sharp Packaging Services (United States)


According to AMA, the market for Clinical Trial Supplies is expected to register a CAGR of 7.3% during the forecast period to 2028. This growth is primarily driven by Globalization of Clinical Trial Activities and Rising Incidences of Various Diseases.

Globally, a noticeable market trend is evident Increasing R&D Investments and Government Support The Health Care Supplies sector in the North America region has been increasing at a sustainable rate, and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as KLIFO A/S (Denmark), Movianto (Germany), lamc Group LTD (United Kingdom), Catalent Pharma Solutions, Inc. (United States), PCI Services (United States), Patheon, Inc. (United States), Biocair (United Kingdom), Thermo Fisher Scientific, Inc. (United States), PAREXEL International Corporation (United States) and Sharp Packaging Services (United States), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years. Expansion of geographic presence and development of niche business units catering to the industry are being currently performed by various players. The Asia Pacific is expected to witness the fastest growth owing to its diverse population, easy access to patients, proximity to North America and low translation costs. Latin America and MEA are also expected to witness significant growth owing to the rise in the number of clinical trials conducted in this region.

Key Developments in the Market:
In May 2022, AkzoNobel Powder Coatings launched a microsite for Resicoat products. The microsite highlights the proven track record of the last 50 years and the experience of our expert technical team who monitor and anticipate changing requirements and regulations to provide support and advice when needed. that.

Influencing Trend:
Increasing R&D Investments and Government Support and Increasing Expansion Activities By Cros

Market Growth Drivers:
Globalization of Clinical Trial Activities and Rising Incidences of Various Diseases

Restraints:
Longer Approval Times for Clinical Trials

Opportunities:
Growing Number of Patent Expirations and Development of Generic Drugs and Increasing Demand from Emerging Markets

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints in Clinical Trial Supplies Market
- Analysis about New Entrants in Clinical Trial Supplies Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis
- An Unbiased Perspective towards Market Performance & Indicators

Against this Challenging Backdrop, Clinical Trial Supplies Study Sheds Light on
— The Clinical Trial Supplies Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Clinical Trial Supplies industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Clinical Trial Supplies industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Manufacturing
  • Packaging and Labeling
  • Logistics and Distribution [Cold chain based, Non-cold chain based]
By Application
  • CNS & Mental Disorders
  • Cardiovascular
  • Oncology
By Phase
  • Phase I
  • Phase II
  • Phase III

By End User
  • Contract Research Organizations
  • Pharmaceutical and Biotechnology Companies

By Therapeutic Area
  • Oncology
  • Cardiovascular Diseases
  • Respiratory Diseases
  • CNS And Mental Disorders
  • Dermatology
  • Blood Disorders
  • Infectious Diseases
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Globalization of Clinical Trial Activities
      • 3.2.2. Rising Incidences of Various Diseases
    • 3.3. Market Trends
      • 3.3.1. Increasing R&D Investments and Government Support
      • 3.3.2. Increasing Expansion Activities By Cros
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Clinical Trial Supplies, by Type, Application, Phase, End User, Therapeutic Area and Region (value and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Clinical Trial Supplies (Value)
      • 5.2.1. Global Clinical Trial Supplies by: Type (Value)
        • 5.2.1.1. Manufacturing
        • 5.2.1.2. Packaging and Labeling
        • 5.2.1.3. Logistics and Distribution [Cold chain based, Non-cold chain based]
      • 5.2.2. Global Clinical Trial Supplies by: Application (Value)
        • 5.2.2.1. CNS & Mental Disorders
        • 5.2.2.2. Cardiovascular
        • 5.2.2.3. Oncology
      • 5.2.3. Global Clinical Trial Supplies by: Phase (Value)
        • 5.2.3.1. Phase I
        • 5.2.3.2. Phase II
        • 5.2.3.3. Phase III
      • 5.2.4. Global Clinical Trial Supplies by: End User (Value)
        • 5.2.4.1. Contract Research Organizations
        • 5.2.4.2. Pharmaceutical and Biotechnology Companies
      • 5.2.5. Global Clinical Trial Supplies by: Therapeutic Area (Value)
        • 5.2.5.1. Oncology
        • 5.2.5.2. Cardiovascular Diseases
        • 5.2.5.3. Respiratory Diseases
        • 5.2.5.4. CNS And Mental Disorders
        • 5.2.5.5. Dermatology
        • 5.2.5.6. Blood Disorders
        • 5.2.5.7. Infectious Diseases
        • 5.2.5.8. Others
      • 5.2.6. Global Clinical Trial Supplies Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
    • 5.3. Global Clinical Trial Supplies (Price)
      • 5.3.1. Global Clinical Trial Supplies by: Type (Price)
  • 6. Clinical Trial Supplies: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. KLIFO A/S (Denmark)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Movianto (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Lamc Group LTD (United Kingdom)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Catalent Pharma Solutions, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. PCI Services (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Patheon, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Biocair (United Kingdom)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Thermo Fisher Scientific, Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. PAREXEL International Corporation (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Sharp Packaging Services (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Clinical Trial Supplies Sale, by Type, Application, Phase, End User, Therapeutic Area and Region (value and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Clinical Trial Supplies (Value)
      • 7.2.1. Global Clinical Trial Supplies by: Type (Value)
        • 7.2.1.1. Manufacturing
        • 7.2.1.2. Packaging and Labeling
        • 7.2.1.3. Logistics and Distribution [Cold chain based, Non-cold chain based]
      • 7.2.2. Global Clinical Trial Supplies by: Application (Value)
        • 7.2.2.1. CNS & Mental Disorders
        • 7.2.2.2. Cardiovascular
        • 7.2.2.3. Oncology
      • 7.2.3. Global Clinical Trial Supplies by: Phase (Value)
        • 7.2.3.1. Phase I
        • 7.2.3.2. Phase II
        • 7.2.3.3. Phase III
      • 7.2.4. Global Clinical Trial Supplies by: End User (Value)
        • 7.2.4.1. Contract Research Organizations
        • 7.2.4.2. Pharmaceutical and Biotechnology Companies
      • 7.2.5. Global Clinical Trial Supplies by: Therapeutic Area (Value)
        • 7.2.5.1. Oncology
        • 7.2.5.2. Cardiovascular Diseases
        • 7.2.5.3. Respiratory Diseases
        • 7.2.5.4. CNS And Mental Disorders
        • 7.2.5.5. Dermatology
        • 7.2.5.6. Blood Disorders
        • 7.2.5.7. Infectious Diseases
        • 7.2.5.8. Others
      • 7.2.6. Global Clinical Trial Supplies Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
    • 7.3. Global Clinical Trial Supplies (Price)
      • 7.3.1. Global Clinical Trial Supplies by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Clinical Trial Supplies: by Type(USD Million)
  • Table 2. Clinical Trial Supplies Manufacturing , by Region USD Million (2017-2022)
  • Table 3. Clinical Trial Supplies Packaging and Labeling , by Region USD Million (2017-2022)
  • Table 4. Clinical Trial Supplies Logistics and Distribution [Cold chain based, Non-cold chain based] , by Region USD Million (2017-2022)
  • Table 5. Clinical Trial Supplies: by Application(USD Million)
  • Table 6. Clinical Trial Supplies CNS & Mental Disorders , by Region USD Million (2017-2022)
  • Table 7. Clinical Trial Supplies Cardiovascular , by Region USD Million (2017-2022)
  • Table 8. Clinical Trial Supplies Oncology , by Region USD Million (2017-2022)
  • Table 9. Clinical Trial Supplies: by Phase(USD Million)
  • Table 10. Clinical Trial Supplies Phase I , by Region USD Million (2017-2022)
  • Table 11. Clinical Trial Supplies Phase II , by Region USD Million (2017-2022)
  • Table 12. Clinical Trial Supplies Phase III , by Region USD Million (2017-2022)
  • Table 13. Clinical Trial Supplies: by End User(USD Million)
  • Table 14. Clinical Trial Supplies Contract Research Organizations , by Region USD Million (2017-2022)
  • Table 15. Clinical Trial Supplies Pharmaceutical and Biotechnology Companies , by Region USD Million (2017-2022)
  • Table 16. Clinical Trial Supplies: by Therapeutic Area(USD Million)
  • Table 17. Clinical Trial Supplies Oncology , by Region USD Million (2017-2022)
  • Table 18. Clinical Trial Supplies Cardiovascular Diseases , by Region USD Million (2017-2022)
  • Table 19. Clinical Trial Supplies Respiratory Diseases , by Region USD Million (2017-2022)
  • Table 20. Clinical Trial Supplies CNS And Mental Disorders , by Region USD Million (2017-2022)
  • Table 21. Clinical Trial Supplies Dermatology , by Region USD Million (2017-2022)
  • Table 22. Clinical Trial Supplies Blood Disorders , by Region USD Million (2017-2022)
  • Table 23. Clinical Trial Supplies Infectious Diseases , by Region USD Million (2017-2022)
  • Table 24. Clinical Trial Supplies Others , by Region USD Million (2017-2022)
  • Table 25. South America Clinical Trial Supplies, by Country USD Million (2017-2022)
  • Table 26. South America Clinical Trial Supplies, by Type USD Million (2017-2022)
  • Table 27. South America Clinical Trial Supplies, by Application USD Million (2017-2022)
  • Table 28. South America Clinical Trial Supplies, by Phase USD Million (2017-2022)
  • Table 29. South America Clinical Trial Supplies, by End User USD Million (2017-2022)
  • Table 30. South America Clinical Trial Supplies, by Therapeutic Area USD Million (2017-2022)
  • Table 31. Brazil Clinical Trial Supplies, by Type USD Million (2017-2022)
  • Table 32. Brazil Clinical Trial Supplies, by Application USD Million (2017-2022)
  • Table 33. Brazil Clinical Trial Supplies, by Phase USD Million (2017-2022)
  • Table 34. Brazil Clinical Trial Supplies, by End User USD Million (2017-2022)
  • Table 35. Brazil Clinical Trial Supplies, by Therapeutic Area USD Million (2017-2022)
  • Table 36. Argentina Clinical Trial Supplies, by Type USD Million (2017-2022)
  • Table 37. Argentina Clinical Trial Supplies, by Application USD Million (2017-2022)
  • Table 38. Argentina Clinical Trial Supplies, by Phase USD Million (2017-2022)
  • Table 39. Argentina Clinical Trial Supplies, by End User USD Million (2017-2022)
  • Table 40. Argentina Clinical Trial Supplies, by Therapeutic Area USD Million (2017-2022)
  • Table 41. Rest of South America Clinical Trial Supplies, by Type USD Million (2017-2022)
  • Table 42. Rest of South America Clinical Trial Supplies, by Application USD Million (2017-2022)
  • Table 43. Rest of South America Clinical Trial Supplies, by Phase USD Million (2017-2022)
  • Table 44. Rest of South America Clinical Trial Supplies, by End User USD Million (2017-2022)
  • Table 45. Rest of South America Clinical Trial Supplies, by Therapeutic Area USD Million (2017-2022)
  • Table 46. Asia Pacific Clinical Trial Supplies, by Country USD Million (2017-2022)
  • Table 47. Asia Pacific Clinical Trial Supplies, by Type USD Million (2017-2022)
  • Table 48. Asia Pacific Clinical Trial Supplies, by Application USD Million (2017-2022)
  • Table 49. Asia Pacific Clinical Trial Supplies, by Phase USD Million (2017-2022)
  • Table 50. Asia Pacific Clinical Trial Supplies, by End User USD Million (2017-2022)
  • Table 51. Asia Pacific Clinical Trial Supplies, by Therapeutic Area USD Million (2017-2022)
  • Table 52. China Clinical Trial Supplies, by Type USD Million (2017-2022)
  • Table 53. China Clinical Trial Supplies, by Application USD Million (2017-2022)
  • Table 54. China Clinical Trial Supplies, by Phase USD Million (2017-2022)
  • Table 55. China Clinical Trial Supplies, by End User USD Million (2017-2022)
  • Table 56. China Clinical Trial Supplies, by Therapeutic Area USD Million (2017-2022)
  • Table 57. Japan Clinical Trial Supplies, by Type USD Million (2017-2022)
  • Table 58. Japan Clinical Trial Supplies, by Application USD Million (2017-2022)
  • Table 59. Japan Clinical Trial Supplies, by Phase USD Million (2017-2022)
  • Table 60. Japan Clinical Trial Supplies, by End User USD Million (2017-2022)
  • Table 61. Japan Clinical Trial Supplies, by Therapeutic Area USD Million (2017-2022)
  • Table 62. India Clinical Trial Supplies, by Type USD Million (2017-2022)
  • Table 63. India Clinical Trial Supplies, by Application USD Million (2017-2022)
  • Table 64. India Clinical Trial Supplies, by Phase USD Million (2017-2022)
  • Table 65. India Clinical Trial Supplies, by End User USD Million (2017-2022)
  • Table 66. India Clinical Trial Supplies, by Therapeutic Area USD Million (2017-2022)
  • Table 67. South Korea Clinical Trial Supplies, by Type USD Million (2017-2022)
  • Table 68. South Korea Clinical Trial Supplies, by Application USD Million (2017-2022)
  • Table 69. South Korea Clinical Trial Supplies, by Phase USD Million (2017-2022)
  • Table 70. South Korea Clinical Trial Supplies, by End User USD Million (2017-2022)
  • Table 71. South Korea Clinical Trial Supplies, by Therapeutic Area USD Million (2017-2022)
  • Table 72. Taiwan Clinical Trial Supplies, by Type USD Million (2017-2022)
  • Table 73. Taiwan Clinical Trial Supplies, by Application USD Million (2017-2022)
  • Table 74. Taiwan Clinical Trial Supplies, by Phase USD Million (2017-2022)
  • Table 75. Taiwan Clinical Trial Supplies, by End User USD Million (2017-2022)
  • Table 76. Taiwan Clinical Trial Supplies, by Therapeutic Area USD Million (2017-2022)
  • Table 77. Australia Clinical Trial Supplies, by Type USD Million (2017-2022)
  • Table 78. Australia Clinical Trial Supplies, by Application USD Million (2017-2022)
  • Table 79. Australia Clinical Trial Supplies, by Phase USD Million (2017-2022)
  • Table 80. Australia Clinical Trial Supplies, by End User USD Million (2017-2022)
  • Table 81. Australia Clinical Trial Supplies, by Therapeutic Area USD Million (2017-2022)
  • Table 82. Rest of Asia-Pacific Clinical Trial Supplies, by Type USD Million (2017-2022)
  • Table 83. Rest of Asia-Pacific Clinical Trial Supplies, by Application USD Million (2017-2022)
  • Table 84. Rest of Asia-Pacific Clinical Trial Supplies, by Phase USD Million (2017-2022)
  • Table 85. Rest of Asia-Pacific Clinical Trial Supplies, by End User USD Million (2017-2022)
  • Table 86. Rest of Asia-Pacific Clinical Trial Supplies, by Therapeutic Area USD Million (2017-2022)
  • Table 87. Europe Clinical Trial Supplies, by Country USD Million (2017-2022)
  • Table 88. Europe Clinical Trial Supplies, by Type USD Million (2017-2022)
  • Table 89. Europe Clinical Trial Supplies, by Application USD Million (2017-2022)
  • Table 90. Europe Clinical Trial Supplies, by Phase USD Million (2017-2022)
  • Table 91. Europe Clinical Trial Supplies, by End User USD Million (2017-2022)
  • Table 92. Europe Clinical Trial Supplies, by Therapeutic Area USD Million (2017-2022)
  • Table 93. Germany Clinical Trial Supplies, by Type USD Million (2017-2022)
  • Table 94. Germany Clinical Trial Supplies, by Application USD Million (2017-2022)
  • Table 95. Germany Clinical Trial Supplies, by Phase USD Million (2017-2022)
  • Table 96. Germany Clinical Trial Supplies, by End User USD Million (2017-2022)
  • Table 97. Germany Clinical Trial Supplies, by Therapeutic Area USD Million (2017-2022)
  • Table 98. France Clinical Trial Supplies, by Type USD Million (2017-2022)
  • Table 99. France Clinical Trial Supplies, by Application USD Million (2017-2022)
  • Table 100. France Clinical Trial Supplies, by Phase USD Million (2017-2022)
  • Table 101. France Clinical Trial Supplies, by End User USD Million (2017-2022)
  • Table 102. France Clinical Trial Supplies, by Therapeutic Area USD Million (2017-2022)
  • Table 103. Italy Clinical Trial Supplies, by Type USD Million (2017-2022)
  • Table 104. Italy Clinical Trial Supplies, by Application USD Million (2017-2022)
  • Table 105. Italy Clinical Trial Supplies, by Phase USD Million (2017-2022)
  • Table 106. Italy Clinical Trial Supplies, by End User USD Million (2017-2022)
  • Table 107. Italy Clinical Trial Supplies, by Therapeutic Area USD Million (2017-2022)
  • Table 108. United Kingdom Clinical Trial Supplies, by Type USD Million (2017-2022)
  • Table 109. United Kingdom Clinical Trial Supplies, by Application USD Million (2017-2022)
  • Table 110. United Kingdom Clinical Trial Supplies, by Phase USD Million (2017-2022)
  • Table 111. United Kingdom Clinical Trial Supplies, by End User USD Million (2017-2022)
  • Table 112. United Kingdom Clinical Trial Supplies, by Therapeutic Area USD Million (2017-2022)
  • Table 113. Netherlands Clinical Trial Supplies, by Type USD Million (2017-2022)
  • Table 114. Netherlands Clinical Trial Supplies, by Application USD Million (2017-2022)
  • Table 115. Netherlands Clinical Trial Supplies, by Phase USD Million (2017-2022)
  • Table 116. Netherlands Clinical Trial Supplies, by End User USD Million (2017-2022)
  • Table 117. Netherlands Clinical Trial Supplies, by Therapeutic Area USD Million (2017-2022)
  • Table 118. Rest of Europe Clinical Trial Supplies, by Type USD Million (2017-2022)
  • Table 119. Rest of Europe Clinical Trial Supplies, by Application USD Million (2017-2022)
  • Table 120. Rest of Europe Clinical Trial Supplies, by Phase USD Million (2017-2022)
  • Table 121. Rest of Europe Clinical Trial Supplies, by End User USD Million (2017-2022)
  • Table 122. Rest of Europe Clinical Trial Supplies, by Therapeutic Area USD Million (2017-2022)
  • Table 123. MEA Clinical Trial Supplies, by Country USD Million (2017-2022)
  • Table 124. MEA Clinical Trial Supplies, by Type USD Million (2017-2022)
  • Table 125. MEA Clinical Trial Supplies, by Application USD Million (2017-2022)
  • Table 126. MEA Clinical Trial Supplies, by Phase USD Million (2017-2022)
  • Table 127. MEA Clinical Trial Supplies, by End User USD Million (2017-2022)
  • Table 128. MEA Clinical Trial Supplies, by Therapeutic Area USD Million (2017-2022)
  • Table 129. Middle East Clinical Trial Supplies, by Type USD Million (2017-2022)
  • Table 130. Middle East Clinical Trial Supplies, by Application USD Million (2017-2022)
  • Table 131. Middle East Clinical Trial Supplies, by Phase USD Million (2017-2022)
  • Table 132. Middle East Clinical Trial Supplies, by End User USD Million (2017-2022)
  • Table 133. Middle East Clinical Trial Supplies, by Therapeutic Area USD Million (2017-2022)
  • Table 134. Africa Clinical Trial Supplies, by Type USD Million (2017-2022)
  • Table 135. Africa Clinical Trial Supplies, by Application USD Million (2017-2022)
  • Table 136. Africa Clinical Trial Supplies, by Phase USD Million (2017-2022)
  • Table 137. Africa Clinical Trial Supplies, by End User USD Million (2017-2022)
  • Table 138. Africa Clinical Trial Supplies, by Therapeutic Area USD Million (2017-2022)
  • Table 139. North America Clinical Trial Supplies, by Country USD Million (2017-2022)
  • Table 140. North America Clinical Trial Supplies, by Type USD Million (2017-2022)
  • Table 141. North America Clinical Trial Supplies, by Application USD Million (2017-2022)
  • Table 142. North America Clinical Trial Supplies, by Phase USD Million (2017-2022)
  • Table 143. North America Clinical Trial Supplies, by End User USD Million (2017-2022)
  • Table 144. North America Clinical Trial Supplies, by Therapeutic Area USD Million (2017-2022)
  • Table 145. United States Clinical Trial Supplies, by Type USD Million (2017-2022)
  • Table 146. United States Clinical Trial Supplies, by Application USD Million (2017-2022)
  • Table 147. United States Clinical Trial Supplies, by Phase USD Million (2017-2022)
  • Table 148. United States Clinical Trial Supplies, by End User USD Million (2017-2022)
  • Table 149. United States Clinical Trial Supplies, by Therapeutic Area USD Million (2017-2022)
  • Table 150. Canada Clinical Trial Supplies, by Type USD Million (2017-2022)
  • Table 151. Canada Clinical Trial Supplies, by Application USD Million (2017-2022)
  • Table 152. Canada Clinical Trial Supplies, by Phase USD Million (2017-2022)
  • Table 153. Canada Clinical Trial Supplies, by End User USD Million (2017-2022)
  • Table 154. Canada Clinical Trial Supplies, by Therapeutic Area USD Million (2017-2022)
  • Table 155. Mexico Clinical Trial Supplies, by Type USD Million (2017-2022)
  • Table 156. Mexico Clinical Trial Supplies, by Application USD Million (2017-2022)
  • Table 157. Mexico Clinical Trial Supplies, by Phase USD Million (2017-2022)
  • Table 158. Mexico Clinical Trial Supplies, by End User USD Million (2017-2022)
  • Table 159. Mexico Clinical Trial Supplies, by Therapeutic Area USD Million (2017-2022)
  • Table 160. Clinical Trial Supplies: by Type(USD/Units)
  • Table 161. Company Basic Information, Sales Area and Its Competitors
  • Table 162. Company Basic Information, Sales Area and Its Competitors
  • Table 163. Company Basic Information, Sales Area and Its Competitors
  • Table 164. Company Basic Information, Sales Area and Its Competitors
  • Table 165. Company Basic Information, Sales Area and Its Competitors
  • Table 166. Company Basic Information, Sales Area and Its Competitors
  • Table 167. Company Basic Information, Sales Area and Its Competitors
  • Table 168. Company Basic Information, Sales Area and Its Competitors
  • Table 169. Company Basic Information, Sales Area and Its Competitors
  • Table 170. Company Basic Information, Sales Area and Its Competitors
  • Table 171. Clinical Trial Supplies: by Type(USD Million)
  • Table 172. Clinical Trial Supplies Manufacturing , by Region USD Million (2023-2028)
  • Table 173. Clinical Trial Supplies Packaging and Labeling , by Region USD Million (2023-2028)
  • Table 174. Clinical Trial Supplies Logistics and Distribution [Cold chain based, Non-cold chain based] , by Region USD Million (2023-2028)
  • Table 175. Clinical Trial Supplies: by Application(USD Million)
  • Table 176. Clinical Trial Supplies CNS & Mental Disorders , by Region USD Million (2023-2028)
  • Table 177. Clinical Trial Supplies Cardiovascular , by Region USD Million (2023-2028)
  • Table 178. Clinical Trial Supplies Oncology , by Region USD Million (2023-2028)
  • Table 179. Clinical Trial Supplies: by Phase(USD Million)
  • Table 180. Clinical Trial Supplies Phase I , by Region USD Million (2023-2028)
  • Table 181. Clinical Trial Supplies Phase II , by Region USD Million (2023-2028)
  • Table 182. Clinical Trial Supplies Phase III , by Region USD Million (2023-2028)
  • Table 183. Clinical Trial Supplies: by End User(USD Million)
  • Table 184. Clinical Trial Supplies Contract Research Organizations , by Region USD Million (2023-2028)
  • Table 185. Clinical Trial Supplies Pharmaceutical and Biotechnology Companies , by Region USD Million (2023-2028)
  • Table 186. Clinical Trial Supplies: by Therapeutic Area(USD Million)
  • Table 187. Clinical Trial Supplies Oncology , by Region USD Million (2023-2028)
  • Table 188. Clinical Trial Supplies Cardiovascular Diseases , by Region USD Million (2023-2028)
  • Table 189. Clinical Trial Supplies Respiratory Diseases , by Region USD Million (2023-2028)
  • Table 190. Clinical Trial Supplies CNS And Mental Disorders , by Region USD Million (2023-2028)
  • Table 191. Clinical Trial Supplies Dermatology , by Region USD Million (2023-2028)
  • Table 192. Clinical Trial Supplies Blood Disorders , by Region USD Million (2023-2028)
  • Table 193. Clinical Trial Supplies Infectious Diseases , by Region USD Million (2023-2028)
  • Table 194. Clinical Trial Supplies Others , by Region USD Million (2023-2028)
  • Table 195. South America Clinical Trial Supplies, by Country USD Million (2023-2028)
  • Table 196. South America Clinical Trial Supplies, by Type USD Million (2023-2028)
  • Table 197. South America Clinical Trial Supplies, by Application USD Million (2023-2028)
  • Table 198. South America Clinical Trial Supplies, by Phase USD Million (2023-2028)
  • Table 199. South America Clinical Trial Supplies, by End User USD Million (2023-2028)
  • Table 200. South America Clinical Trial Supplies, by Therapeutic Area USD Million (2023-2028)
  • Table 201. Brazil Clinical Trial Supplies, by Type USD Million (2023-2028)
  • Table 202. Brazil Clinical Trial Supplies, by Application USD Million (2023-2028)
  • Table 203. Brazil Clinical Trial Supplies, by Phase USD Million (2023-2028)
  • Table 204. Brazil Clinical Trial Supplies, by End User USD Million (2023-2028)
  • Table 205. Brazil Clinical Trial Supplies, by Therapeutic Area USD Million (2023-2028)
  • Table 206. Argentina Clinical Trial Supplies, by Type USD Million (2023-2028)
  • Table 207. Argentina Clinical Trial Supplies, by Application USD Million (2023-2028)
  • Table 208. Argentina Clinical Trial Supplies, by Phase USD Million (2023-2028)
  • Table 209. Argentina Clinical Trial Supplies, by End User USD Million (2023-2028)
  • Table 210. Argentina Clinical Trial Supplies, by Therapeutic Area USD Million (2023-2028)
  • Table 211. Rest of South America Clinical Trial Supplies, by Type USD Million (2023-2028)
  • Table 212. Rest of South America Clinical Trial Supplies, by Application USD Million (2023-2028)
  • Table 213. Rest of South America Clinical Trial Supplies, by Phase USD Million (2023-2028)
  • Table 214. Rest of South America Clinical Trial Supplies, by End User USD Million (2023-2028)
  • Table 215. Rest of South America Clinical Trial Supplies, by Therapeutic Area USD Million (2023-2028)
  • Table 216. Asia Pacific Clinical Trial Supplies, by Country USD Million (2023-2028)
  • Table 217. Asia Pacific Clinical Trial Supplies, by Type USD Million (2023-2028)
  • Table 218. Asia Pacific Clinical Trial Supplies, by Application USD Million (2023-2028)
  • Table 219. Asia Pacific Clinical Trial Supplies, by Phase USD Million (2023-2028)
  • Table 220. Asia Pacific Clinical Trial Supplies, by End User USD Million (2023-2028)
  • Table 221. Asia Pacific Clinical Trial Supplies, by Therapeutic Area USD Million (2023-2028)
  • Table 222. China Clinical Trial Supplies, by Type USD Million (2023-2028)
  • Table 223. China Clinical Trial Supplies, by Application USD Million (2023-2028)
  • Table 224. China Clinical Trial Supplies, by Phase USD Million (2023-2028)
  • Table 225. China Clinical Trial Supplies, by End User USD Million (2023-2028)
  • Table 226. China Clinical Trial Supplies, by Therapeutic Area USD Million (2023-2028)
  • Table 227. Japan Clinical Trial Supplies, by Type USD Million (2023-2028)
  • Table 228. Japan Clinical Trial Supplies, by Application USD Million (2023-2028)
  • Table 229. Japan Clinical Trial Supplies, by Phase USD Million (2023-2028)
  • Table 230. Japan Clinical Trial Supplies, by End User USD Million (2023-2028)
  • Table 231. Japan Clinical Trial Supplies, by Therapeutic Area USD Million (2023-2028)
  • Table 232. India Clinical Trial Supplies, by Type USD Million (2023-2028)
  • Table 233. India Clinical Trial Supplies, by Application USD Million (2023-2028)
  • Table 234. India Clinical Trial Supplies, by Phase USD Million (2023-2028)
  • Table 235. India Clinical Trial Supplies, by End User USD Million (2023-2028)
  • Table 236. India Clinical Trial Supplies, by Therapeutic Area USD Million (2023-2028)
  • Table 237. South Korea Clinical Trial Supplies, by Type USD Million (2023-2028)
  • Table 238. South Korea Clinical Trial Supplies, by Application USD Million (2023-2028)
  • Table 239. South Korea Clinical Trial Supplies, by Phase USD Million (2023-2028)
  • Table 240. South Korea Clinical Trial Supplies, by End User USD Million (2023-2028)
  • Table 241. South Korea Clinical Trial Supplies, by Therapeutic Area USD Million (2023-2028)
  • Table 242. Taiwan Clinical Trial Supplies, by Type USD Million (2023-2028)
  • Table 243. Taiwan Clinical Trial Supplies, by Application USD Million (2023-2028)
  • Table 244. Taiwan Clinical Trial Supplies, by Phase USD Million (2023-2028)
  • Table 245. Taiwan Clinical Trial Supplies, by End User USD Million (2023-2028)
  • Table 246. Taiwan Clinical Trial Supplies, by Therapeutic Area USD Million (2023-2028)
  • Table 247. Australia Clinical Trial Supplies, by Type USD Million (2023-2028)
  • Table 248. Australia Clinical Trial Supplies, by Application USD Million (2023-2028)
  • Table 249. Australia Clinical Trial Supplies, by Phase USD Million (2023-2028)
  • Table 250. Australia Clinical Trial Supplies, by End User USD Million (2023-2028)
  • Table 251. Australia Clinical Trial Supplies, by Therapeutic Area USD Million (2023-2028)
  • Table 252. Rest of Asia-Pacific Clinical Trial Supplies, by Type USD Million (2023-2028)
  • Table 253. Rest of Asia-Pacific Clinical Trial Supplies, by Application USD Million (2023-2028)
  • Table 254. Rest of Asia-Pacific Clinical Trial Supplies, by Phase USD Million (2023-2028)
  • Table 255. Rest of Asia-Pacific Clinical Trial Supplies, by End User USD Million (2023-2028)
  • Table 256. Rest of Asia-Pacific Clinical Trial Supplies, by Therapeutic Area USD Million (2023-2028)
  • Table 257. Europe Clinical Trial Supplies, by Country USD Million (2023-2028)
  • Table 258. Europe Clinical Trial Supplies, by Type USD Million (2023-2028)
  • Table 259. Europe Clinical Trial Supplies, by Application USD Million (2023-2028)
  • Table 260. Europe Clinical Trial Supplies, by Phase USD Million (2023-2028)
  • Table 261. Europe Clinical Trial Supplies, by End User USD Million (2023-2028)
  • Table 262. Europe Clinical Trial Supplies, by Therapeutic Area USD Million (2023-2028)
  • Table 263. Germany Clinical Trial Supplies, by Type USD Million (2023-2028)
  • Table 264. Germany Clinical Trial Supplies, by Application USD Million (2023-2028)
  • Table 265. Germany Clinical Trial Supplies, by Phase USD Million (2023-2028)
  • Table 266. Germany Clinical Trial Supplies, by End User USD Million (2023-2028)
  • Table 267. Germany Clinical Trial Supplies, by Therapeutic Area USD Million (2023-2028)
  • Table 268. France Clinical Trial Supplies, by Type USD Million (2023-2028)
  • Table 269. France Clinical Trial Supplies, by Application USD Million (2023-2028)
  • Table 270. France Clinical Trial Supplies, by Phase USD Million (2023-2028)
  • Table 271. France Clinical Trial Supplies, by End User USD Million (2023-2028)
  • Table 272. France Clinical Trial Supplies, by Therapeutic Area USD Million (2023-2028)
  • Table 273. Italy Clinical Trial Supplies, by Type USD Million (2023-2028)
  • Table 274. Italy Clinical Trial Supplies, by Application USD Million (2023-2028)
  • Table 275. Italy Clinical Trial Supplies, by Phase USD Million (2023-2028)
  • Table 276. Italy Clinical Trial Supplies, by End User USD Million (2023-2028)
  • Table 277. Italy Clinical Trial Supplies, by Therapeutic Area USD Million (2023-2028)
  • Table 278. United Kingdom Clinical Trial Supplies, by Type USD Million (2023-2028)
  • Table 279. United Kingdom Clinical Trial Supplies, by Application USD Million (2023-2028)
  • Table 280. United Kingdom Clinical Trial Supplies, by Phase USD Million (2023-2028)
  • Table 281. United Kingdom Clinical Trial Supplies, by End User USD Million (2023-2028)
  • Table 282. United Kingdom Clinical Trial Supplies, by Therapeutic Area USD Million (2023-2028)
  • Table 283. Netherlands Clinical Trial Supplies, by Type USD Million (2023-2028)
  • Table 284. Netherlands Clinical Trial Supplies, by Application USD Million (2023-2028)
  • Table 285. Netherlands Clinical Trial Supplies, by Phase USD Million (2023-2028)
  • Table 286. Netherlands Clinical Trial Supplies, by End User USD Million (2023-2028)
  • Table 287. Netherlands Clinical Trial Supplies, by Therapeutic Area USD Million (2023-2028)
  • Table 288. Rest of Europe Clinical Trial Supplies, by Type USD Million (2023-2028)
  • Table 289. Rest of Europe Clinical Trial Supplies, by Application USD Million (2023-2028)
  • Table 290. Rest of Europe Clinical Trial Supplies, by Phase USD Million (2023-2028)
  • Table 291. Rest of Europe Clinical Trial Supplies, by End User USD Million (2023-2028)
  • Table 292. Rest of Europe Clinical Trial Supplies, by Therapeutic Area USD Million (2023-2028)
  • Table 293. MEA Clinical Trial Supplies, by Country USD Million (2023-2028)
  • Table 294. MEA Clinical Trial Supplies, by Type USD Million (2023-2028)
  • Table 295. MEA Clinical Trial Supplies, by Application USD Million (2023-2028)
  • Table 296. MEA Clinical Trial Supplies, by Phase USD Million (2023-2028)
  • Table 297. MEA Clinical Trial Supplies, by End User USD Million (2023-2028)
  • Table 298. MEA Clinical Trial Supplies, by Therapeutic Area USD Million (2023-2028)
  • Table 299. Middle East Clinical Trial Supplies, by Type USD Million (2023-2028)
  • Table 300. Middle East Clinical Trial Supplies, by Application USD Million (2023-2028)
  • Table 301. Middle East Clinical Trial Supplies, by Phase USD Million (2023-2028)
  • Table 302. Middle East Clinical Trial Supplies, by End User USD Million (2023-2028)
  • Table 303. Middle East Clinical Trial Supplies, by Therapeutic Area USD Million (2023-2028)
  • Table 304. Africa Clinical Trial Supplies, by Type USD Million (2023-2028)
  • Table 305. Africa Clinical Trial Supplies, by Application USD Million (2023-2028)
  • Table 306. Africa Clinical Trial Supplies, by Phase USD Million (2023-2028)
  • Table 307. Africa Clinical Trial Supplies, by End User USD Million (2023-2028)
  • Table 308. Africa Clinical Trial Supplies, by Therapeutic Area USD Million (2023-2028)
  • Table 309. North America Clinical Trial Supplies, by Country USD Million (2023-2028)
  • Table 310. North America Clinical Trial Supplies, by Type USD Million (2023-2028)
  • Table 311. North America Clinical Trial Supplies, by Application USD Million (2023-2028)
  • Table 312. North America Clinical Trial Supplies, by Phase USD Million (2023-2028)
  • Table 313. North America Clinical Trial Supplies, by End User USD Million (2023-2028)
  • Table 314. North America Clinical Trial Supplies, by Therapeutic Area USD Million (2023-2028)
  • Table 315. United States Clinical Trial Supplies, by Type USD Million (2023-2028)
  • Table 316. United States Clinical Trial Supplies, by Application USD Million (2023-2028)
  • Table 317. United States Clinical Trial Supplies, by Phase USD Million (2023-2028)
  • Table 318. United States Clinical Trial Supplies, by End User USD Million (2023-2028)
  • Table 319. United States Clinical Trial Supplies, by Therapeutic Area USD Million (2023-2028)
  • Table 320. Canada Clinical Trial Supplies, by Type USD Million (2023-2028)
  • Table 321. Canada Clinical Trial Supplies, by Application USD Million (2023-2028)
  • Table 322. Canada Clinical Trial Supplies, by Phase USD Million (2023-2028)
  • Table 323. Canada Clinical Trial Supplies, by End User USD Million (2023-2028)
  • Table 324. Canada Clinical Trial Supplies, by Therapeutic Area USD Million (2023-2028)
  • Table 325. Mexico Clinical Trial Supplies, by Type USD Million (2023-2028)
  • Table 326. Mexico Clinical Trial Supplies, by Application USD Million (2023-2028)
  • Table 327. Mexico Clinical Trial Supplies, by Phase USD Million (2023-2028)
  • Table 328. Mexico Clinical Trial Supplies, by End User USD Million (2023-2028)
  • Table 329. Mexico Clinical Trial Supplies, by Therapeutic Area USD Million (2023-2028)
  • Table 330. Clinical Trial Supplies: by Type(USD/Units)
  • Table 331. Research Programs/Design for This Report
  • Table 332. Key Data Information from Secondary Sources
  • Table 333. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Clinical Trial Supplies: by Type USD Million (2017-2022)
  • Figure 5. Global Clinical Trial Supplies: by Application USD Million (2017-2022)
  • Figure 6. Global Clinical Trial Supplies: by Phase USD Million (2017-2022)
  • Figure 7. Global Clinical Trial Supplies: by End User USD Million (2017-2022)
  • Figure 8. Global Clinical Trial Supplies: by Therapeutic Area USD Million (2017-2022)
  • Figure 9. South America Clinical Trial Supplies Share (%), by Country
  • Figure 10. Asia Pacific Clinical Trial Supplies Share (%), by Country
  • Figure 11. Europe Clinical Trial Supplies Share (%), by Country
  • Figure 12. MEA Clinical Trial Supplies Share (%), by Country
  • Figure 13. North America Clinical Trial Supplies Share (%), by Country
  • Figure 14. Global Clinical Trial Supplies: by Type USD/Units (2017-2022)
  • Figure 15. Global Clinical Trial Supplies share by Players 2022 (%)
  • Figure 16. Global Clinical Trial Supplies share by Players (Top 3) 2022(%)
  • Figure 17. Global Clinical Trial Supplies share by Players (Top 5) 2022(%)
  • Figure 18. BCG Matrix for key Companies
  • Figure 19. KLIFO A/S (Denmark) Revenue, Net Income and Gross profit
  • Figure 20. KLIFO A/S (Denmark) Revenue: by Geography 2022
  • Figure 21. Movianto (Germany) Revenue, Net Income and Gross profit
  • Figure 22. Movianto (Germany) Revenue: by Geography 2022
  • Figure 23. Lamc Group LTD (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 24. Lamc Group LTD (United Kingdom) Revenue: by Geography 2022
  • Figure 25. Catalent Pharma Solutions, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Catalent Pharma Solutions, Inc. (United States) Revenue: by Geography 2022
  • Figure 27. PCI Services (United States) Revenue, Net Income and Gross profit
  • Figure 28. PCI Services (United States) Revenue: by Geography 2022
  • Figure 29. Patheon, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. Patheon, Inc. (United States) Revenue: by Geography 2022
  • Figure 31. Biocair (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 32. Biocair (United Kingdom) Revenue: by Geography 2022
  • Figure 33. Thermo Fisher Scientific, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 34. Thermo Fisher Scientific, Inc. (United States) Revenue: by Geography 2022
  • Figure 35. PAREXEL International Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 36. PAREXEL International Corporation (United States) Revenue: by Geography 2022
  • Figure 37. Sharp Packaging Services (United States) Revenue, Net Income and Gross profit
  • Figure 38. Sharp Packaging Services (United States) Revenue: by Geography 2022
  • Figure 39. Global Clinical Trial Supplies: by Type USD Million (2023-2028)
  • Figure 40. Global Clinical Trial Supplies: by Application USD Million (2023-2028)
  • Figure 41. Global Clinical Trial Supplies: by Phase USD Million (2023-2028)
  • Figure 42. Global Clinical Trial Supplies: by End User USD Million (2023-2028)
  • Figure 43. Global Clinical Trial Supplies: by Therapeutic Area USD Million (2023-2028)
  • Figure 44. South America Clinical Trial Supplies Share (%), by Country
  • Figure 45. Asia Pacific Clinical Trial Supplies Share (%), by Country
  • Figure 46. Europe Clinical Trial Supplies Share (%), by Country
  • Figure 47. MEA Clinical Trial Supplies Share (%), by Country
  • Figure 48. North America Clinical Trial Supplies Share (%), by Country
  • Figure 49. Global Clinical Trial Supplies: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • KLIFO A/S (Denmark)
  • Movianto (Germany)
  • lamc Group LTD (United Kingdom)
  • Catalent Pharma Solutions, Inc. (United States)
  • PCI Services (United States)
  • Patheon, Inc. (United States)
  • Biocair (United Kingdom)
  • Thermo Fisher Scientific, Inc. (United States)
  • PAREXEL International Corporation (United States)
  • Sharp Packaging Services (United States)
Select User Access Type

Key Highlights of Report


Sep 2023 234 Pages 75 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Clinical Trial Supplies Quantitative research analysis
Global Clinical Trial Supplies Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global Clinical Trial Supplies market are KLIFO A/S (Denmark), Movianto (Germany), lamc Group LTD (United Kingdom), Catalent Pharma Solutions, Inc. (United States), PCI Services (United States), Patheon, Inc. (United States), Biocair (United Kingdom), Thermo Fisher Scientific, Inc. (United States), PAREXEL International Corporation (United States) and Sharp Packaging Services (United States), to name a few.
North America is dominating the Clinical Trial Supplies Market.
"" is seen as one of the major challenges by many Industry Players of Clinical Trial Supplies Market
The Clinical Trial Supplies market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get complete companies available in our research coverage.
The Clinical Trial Supplies market is expected to see a steady growth rate during projected year 2022 to 2028.

Know More About Global Clinical Trial Supplies Report?

Have a Query? Click Here

Other Related Reports

Tubeless Insulin Pump Comprehensive Study by Type (Pod/Patch, Remote, Others), Application (Pharmacies, Hospitals, E-commerce, Others) Players and Region - Global Market Outlook to 2030
$ 3500
Lemon Terpenes Comprehensive Study by Type (Purity 95%, Purity 98%, Other), Application (Cosmetics, Medical, Edible Flavor, Other), Distribution Channel (Supplier, Distributer, Retailer, Others) Play...
$ 3500
Health Functional Food Comprehensive Study by Type (Tablets, Capsules, Powders, Others), Application (Sports Nutrition, Weight Management Food, Dietary Supplements, Other), Ingredients (Dietary Fiber...
$ 3450
Thawing System Comprehensive Study by Type (Manual Devices, Automated Devices), Application (Blood Banks & Transfusion Centers, Hospitals & Diagnostic Laboratories, Cord Blood and Stem Cell Banks, Re...
$ 3750
Laser Eye Shield Comprehensive Study by Type (Autoclavable, Single-Use), Application (Hospital, Clinic, Personal Care, Other), Distribution Channel (Online, Offline) Players and Region - Global Marke...
$ 3500
Roman Chamomile Oil Comprehensive Study by Type (Natural, Synthetic), Application (Cosmetics, Medical, Others), Quality (High-Quality, Middle-Quality, Low-Quality), End Use (Aromatherapy, Personal Ca...
$ 3450